Industry News
“ Reston, VA–Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage. According to research published in the December issue of The Journal of Nuclear Medicine, 68Ga-FAPI-04 positron emission tomography (PET) can effectively image fibroblast activation after myocardial…
Read More
In a News Release on Eureka Alert, comes a fascinating example of how cameras were used in patient care combined with machine learning to better identify and improve lifestyle strategies for heart failure patients. The article titled “Tiny wearable cameras may improve quality of life in heart failure patients” and is an outstanding example of…
Read More
Meet with Christopher Kata, Director of Sales & Marketing on August 19th – 21st, 2019 in Tampa, Florida! Christopher Kata, Director of Sales & Marketing905 [email protected] When: August 19th to 21st 2019Where: Tampa, Florida Christopher Kata is in Tampa for meetings all three days and has some availability for additional meetings. If you’re interested in…
Read More
From Clinical Leader comes a very timely article on the state of interoperability within clinical research Clinical Trials today can benefit tremendously as a result of the value produced from integration with EMR systems, leveraging Real World Data and Real World Evidence, and the adoption of eSource! “Three decades ago when I entered the profession…
Read More
WideTrial , one of TrialStat’s strategic partners has partnered with Oncotelic to bring the Expanded Access Platform to Cancer. June 03, 2019 (ACCESSWIRE via COMTEX) — SAN FRANCISCO, CA / ACCESSWIRE / June 3, 2019 / WideTrial Inc., a third-party sponsor of Expanded Access programs, has begun a partnership with Oncotelic Inc., a wholly owned subsidiary…
Read More
The goal of Project Facilitate is to make it easier for oncologists or healthcare providers without the regulatory experience or resources to navigate the single patient IND process. “Access to clinical trials and access to novel therapeutics for patients is still a problem. We know that not all oncologists or healthcare providers have the regulatory…
Read More In March of 2019 the FDA released this statement regarding the value of Expanded Access Programs and the FDA’s encouragement of Sponsors to consider providing them as options for Patient Populations. A few interesting statements worth highlighting in the statement: “Since 2010, drug sponsors and manufacturers have given the opportunity of such access to more…
Read More
The Diagnostic and Interventional Cardiology website posted an important article about recent proposed changes by the FDA which may allow Institutional Review Boards (IRB) to waive or alter informed consent requirements for clinical studies that pose minimal risk to human participants. The conditions under which an IRB could do this are limited and detailed in the…
Read More
The FDA has announced it is taking additioanl steps to improve the security of Medical Devices. The agency will soon release a new draft of premarket guidance document with recommendations to combat growing security threats. “In addition, the agency announced multiple partnerships with manufacturers, hospitals and more — as well as the release of a…
Read More
MassDevice has written an excellent article outlining the benefits Medical Device Trials receive when using a Unified eClinical Suite. “Implementing a unified data platform for medical device trials can yield significant improvements in efficiency, transparency, and standardization, providing resource- and budget-strapped trial teams with accessible, more accurate data for faster, more informed decisions.” Read The…
Read More